About this trial

An important feature of neurosurgical anesthesia is early postoperative recovery of consciousness with minimal residual sedation. This is a key factor to enable early neurological assessment and early discovery of postoperative complications.

The goal of this single centre clinical trial is to compare propofol/remifentanil anesthesia delivered by manual total intravenous anesthesia (mTIVA) or target controlled infusion (TCI) for intracranial tumor resection via craniotomy. Anesthetic depth will be assessed by a simplified processed EEG (pEEG).

The main question is time spent within recommended pEEG- levels from anesthesia induction until end of surgery.

Secondary questions are:

* mean pEEG-level, time from end of surgery to consiousness, * peroperative propofol/remifentanil consumption * postoperative degree of sleepiness * awareness assessment

Participants are adults having have planned surgery for open resection of a brain tumor and will receive general anesthesia with propofol and remifentanil randomized to mTIVA or TCI. pEEG vill be blinded.

* Participants will be asked to grade postoperative sleepiness using a specific scale * Follow up regarding awareness will be performed.

Eligibility criteria

Qualifiers

Elective craniotomy for tumor resection

Adult patient

Consent to participation

Disqualifiers

Cognitive impact affecting infrmed consent

brain tumor planned for biopsy without resection Tumor localisation not permitting placement of pEEG electrodes.

Trial design

Treatments tested in this trial

  • depth of anesthesia

Treatment groups

126 Participants
are divided into 2 treatment groups

Locations

1
Anesthesia and Intensive Care, Skane University Hospital22185, Lund Sweden

Sponsors and collaborators

Region Skane

Lead sponsor